Bevacizumab Biosimilar Could Drive Up Costs
New study finds an anti-VEGF biosimilar could increase costs to patients and the healthcare system.
Panfacial Necrosis Reported in Immunodeficient Patients with Mpox
Mpox manifestations in patients with untreated HIV/AIDS bear striking resemblance to progressive vaccinia.
A New Model for Studying Corneal Diseases
Experimental organoid-based system could offer a leap forward for research into blinding corneal diseases.
AI Predicts Outcomes & Treatment Frequency for Retinal Vein Occlusion
In patients treated for macular edema with intravitreal aflibercept, AI may provide insights into personalized treatments.
Ranibizumab Port Delivery System: Is There a Cost Benefit?
Comparison study presents a model for investigating costs of intravitreal anti-VEGF injections vs. ranibizumab PDS for nAMD.
NYU Langone Health: A Leader in Ophthalmology
USNWR Best Hospitals
$4M+ in NIH funding, including the multi-center Zoster Eye Disease Study
annual patient visits
Get Practice-Changing Specialty News from Experts in the Field
Select your areas of interest to receive expert perspectives, complex cases, and research updates from one of America’s top hospitals.